biotech

Biotech IPOs in 2023: Shaping the Future of Innovation
Xtalks
Wed, 05/31/23 - 06:52 pm
biotech
IPOs
Serial biotech founder Tim Springer on investing in startups and democratizing antibody research
BioPharma Dive
Fri, 05/26/23 - 09:47 am
Tim Springer
Harvard
biotech
R&D
3 Key Biotech Trends for 2023 And Beyond
Motley Fool
Fri, 05/19/23 - 10:13 am
biotech
collaboration
artificial intelligence
clinical trials
drug development
So you think you can go public? Few biotechs dance with Wall Street
Fierce Biotech
Mon, 05/8/23 - 11:52 pm
biotech
IPOs
Structure Therapeutics
Mineralys Therapeutics
Coya Therapeutics
After a record run, fewer biotechs are going public. Here’s how they’re performing.
BioPharma Dive
Fri, 04/14/23 - 10:21 am
biotech
IPOs
Biotechs see 'staggering' 87% rise in layoffs during Q1, on pace to overtake 2022
Fierce Biotech
Thu, 04/13/23 - 12:03 pm
layoffs
biotech
Biotech layoffs gather pace as industry downturn persists
BioPharma Dive
Tue, 04/11/23 - 07:18 pm
layoffs
biotech
Amgen
Pfizer
Roche
Jounce Therapeutics
Fate Therapeutics
Molecular Templates
Sorrento Therapeutics
Biopharma Rallies Behind FDA After Texas Abortion Pill Ruling
BioSpace
Tue, 04/11/23 - 11:44 am
biotech
FDA
Texas
legal
mifepristone
abortion pill
Biotech leaders 'cannot stay quiet' as judge blocks abortion pill approval
Fierce Biotech
Mon, 04/10/23 - 11:38 am
biotech
FDA
legal
abortion pill
mifepristone
Floating biotechs prompt tiny sparks of hope
EP Vantage
Mon, 04/10/23 - 11:16 am
IPOs
biotech
Mineralys Therapeutics
Structure Therapeutics
Genelux
Cadrenal Therapeutics
A stealth biotech startup is quietly advancing a new drugmaking tool from David Liu’s lab
BioPharma Dive
Wed, 04/5/23 - 07:22 pm
startups
biotech
Beam Therapeutics
Prime Medicine
Resonance Medicine
David Liu
As market stays cold, biotechs continue to cut programs, trials and staff
Endpoints
Tue, 04/4/23 - 11:33 pm
biotech
layoffs
Freeline Therapeutics
Oncternal
Tonix Pharmaceuticals
VBI Vaccines
Record growth in U.S. life sciences real estate footprint
Axios
Tue, 04/4/23 - 12:31 pm
life sciences
R&D
biotech
Cure Ventures unveils inaugural $350M fund with focus on diligent seed rounds to de-risk new science
Fierce Biotech
Tue, 04/4/23 - 10:21 am
Cure Ventures
biotech
funding
venture capital
US government announces ambitions for biomanufacturing
Biopharma Reporter
Mon, 04/3/23 - 10:11 am
federal government
biotech
drug manufacturing
Top biotech licensing deals of Q1 2023
BioSpace
Thu, 03/30/23 - 11:03 am
biotech
licensing
Moderna Therapeutics
CytomX
Voyager Therapeutics
Neurocrine Biosciences
Kronos Bio
Genentech
Karuna Therapeutics
Goldfinch Bio
Biotech heads towards big catalysts
EP Vantage
Tue, 03/28/23 - 10:24 am
biotech
clinical trials
Alnylam Pharmaceuticals
Arcus Biosciences
Argenx
Arrowhead Pharmaceuticals
Axsome Therapeutics
Bavarian Nordic
FibroGen
Gilead Sciences
Incyte
Morphic Therapeutic
PTC Therapeutics
Syndax Pharmaceuticals
Travere Therapeutics
Vaxcyte
‘Huge boost for biotech companies’: UK life sciences industry welcomes new enhanced R&D tax relief rate
Biopharma Reporter
Thu, 03/23/23 - 11:11 am
biotech
UK
innovation
R&D
Europe rues SVB loss as a cornerstone life science supporter
EP Vantage
Thu, 03/16/23 - 09:22 am
SVB
biotech
life sciences
Europe
Silicon Valley Bank: biopharma’s latest crisis
EP Vantage
Tue, 03/14/23 - 10:55 am
SVB
biotech

Pages